By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Monday, December 13rd. Please refresh for updates.
Pfizer (NYSE:PFE) stock rose 1.2% and BioNTech (NASDAQ:BNTX) stock rose 3.9% after an Israeli study showed their Covid-19 vaccine booster provides good protection against severe illness from the Omicron variant. Pfizer has also agreed to acquire Arena Pharmaceuticals (NASDAQ:ARNA) in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline. Arena stock soared over 90%.
Harley-Davidson (NYSE:HOG) stock rose 10% after the iconic motorcycle maker announced it’s merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the NYSE.
Intel (NASDAQ:INTC) stock rose 0.3% after local authorities indicated that the chip manufacturer is set to invest over $7.1 billion in a new, state-of-the-art facility in Malaysia.
Credit Suisse (SIX:CSGN) stock rose 0.3% after the Swiss banking giant revamped its executive board, seeking to move on from a difficult year during which it was battered by a stream of controversies and losses.
Lucid (NASDAQ:LCID) stock rose 6.6% after the luxury EV-maker said the $1.75-billion debt paper it is raising will be convertible at a 50% premium to its December 9 share price, pricing more tightly than expected pointing to lenders’ confidence in the company’s long term future.
Microsoft (NASDAQ:MSFT) stock rose 0.1% following a Reuters report stating that the U.K. antitrust regulator will look into the company’s $16-billion purchase of artificial intelligence and speech technology firm Nuance Communications (NASDAQ:NUAN).
- Apple (NASDAQ:AAPL) stock rose 1.2% after JPMorgan raised its price target on the iPhone maker to $210 from $180, the highest on Wall Street, citing the likely launch of a 5G iPhone SE.
Coca-Cola (NYSE:KO) stock rose 1.2% after JPMorgan (NYSE:JPM) upgraded its stance on the soft drinks giant to ‘overweight’ from ‘neutral’, saying reopenings and higher prices will boost its revenue going into 2022.
Bristol-Myers Squibb (NYSE:BMY) stock rose 1.9% after the pharmaceutical giant announced a 10% increase in its quarterly dividend and added $15 billion to its share buyback authorization.
Qualcomm (NASDAQ:QCOM) stock rose 1.6% after JPMorgan named the chip manufacturer as one of its top picks for 2022.
Should you invest $2,000 in INTC right now?
With INTC making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed INTC alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including INTC, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is INTC poised for similar growth? Don't miss the opportunity to find out.
Reveal Undervalued Stocks Now